Acute inflammatory thyromegaly following checkpoint inhibition: A new imaging entity?

by Erik H. Middlebrooks, MD, Brian C. Westbrook, MS-2, Robert M. Conry, MD
Published 2018-02-01

Talimogene laherparepvec for regionally advanced Merkel cell carcinoma: A report of 2 cases

by Jonathan T. Blackmon, Ratika Dhawan, MBBS, MPH, Toni M. Viator, RN, Nina L. Terry, MD, JD, Robert M. Conry, MD
Published 2017-05-01

Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years

by Timothy G. Norwood, Carrie A. Lenneman, MD, Brian C. Westbrook, Silvio H. Litovsky, MD, Svetlana B. McKee, RN, BSN, Robert M. Conry, MD
Published 2020-02-01

Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec

by Jonathan T. Blackmon, Michael S. Stratton, MD, Young Kwak, MD, Peter G. Pavlidakey, MD, Andrzej T. Slominski, MD, Svetlana B. McKee, RN, BSN, Toni M. Viator, RN, Ju Young Kim, PhD, Conway C. Huang, MD, Robert M. Conry, MD
Published 2017-07-01

A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases

by John B. Fiveash, MD, Waleed O. Arafat, MD, PhD, George E. Naoum, MD, Barton L. Guthrie, MD, Stephen M. Sawrie, MD, Sharon A. Spencer, MD, Ruby F. Meredith, MD, PhD, James M. Markert, MD, PhD, Robert M. Conry, MD, Burt L. Nabors, MD
Published 2016-04-01